Leviticus Partners

Leviticus Partners is a New York-based investment partnership and hedge fund that specializes in value-oriented, micro-cap investments, with a significant focus on the healthcare and life sciences sectors. Managed by AMH Equity LLC and led by founder Adam M. Hutt, the firm identifies underfollowed companies with strong operating histories and intrinsic value that is not reflected in their current stock prices. Leviticus Partners often takes significant passive or active stakes in its portfolio companies, such as Harvard Bioscience and Lantronix, to drive long-term value through strategic engagement. The firm's investment strategy emphasizes deep fundamental research and a long-biased approach to achieve superior returns relative to major indices.